Skip to main content
. Author manuscript; available in PMC: 2010 Jul 1.
Published in final edited form as: Lancet Oncol. 2009 Jul;10(7):718–726. doi: 10.1016/S1470-2045(09)70082-8

Figure 2.

Figure 2

Changes in irradiated tumor (A) promote rejection by effector T cells (B). Tumor antigen-loaded DC migrate to lymph nodes and activate T cells (C) that inhibit metastases (D).